Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazufloxacin vs levofloxacin in community-acquired pneumonia and acute exacerbation of chronic bronchitis
CTR20132601Phase 3Completed
- Sponsor
- Beijing Sihuan Kebao Pharmaceutical
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pazufloxacin in community-acquired pneumonia (CAP), chronic bronchitis (CB), sponsored by Beijing Sihuan Kebao Pharmaceutical. Started Jan 2014; status: completed.
02
Drugs
pazufloxacin
03
Conditions
community-acquired pneumonia (CAP)chronic bronchitis (CB)
Beyond the preview
Go deeper on CTR20132601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132601.